Advertisement

Nabriva Therapeutics plc NBRV

Set alert

Price alert · NBRV

All alert types
1.42 +1.42 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
4.96M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.18
Beta
1.55
Short ratio
6.12
Inst. own
9.21%
Dividend
0.00
Ex-div date
Earnings
Aug 2, 2023
50-d avg
1.57
200-d avg
1.83
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NBRV has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue by
Other Income → Expenses: $388.00KProduct revenue, net → Revenue: $7.56MExpenses → Selling, General & Admin: $9.00MExpenses → Research & Development: $2.63MExpenses → Interest Expense: $194.00KExpenses → Income Tax: $419.00KGross Profit → Expenses: $3.15MRevenue → Gross Profit: $3.15MRevenue → Cost of Revenue: $4.44MNet Loss → Expenses: $8.70MCollaboration revenue → Revenue: $29.00KOther Income$388.00KGross Profit$3.15MNet Loss$8.70MCost of Revenue$4.44MExpenses$12.24MSelling, General & Admin$9.00MResearch & Development$2.63MInterest Expense$194.00KIncome Tax$419.00KRevenue$7.59MProduct revenue, net$7.56MCollaboration revenue$29.00K

Period ending Mar 31, 2023 · select a line to chart its history

Income statement

NBRV quarterly income statement
7.59M
7.59M
4.44M
3.15M
11.63M
2.63M
9.00M
-8.47M
194.00K
-8.70M
-8.70M
-8.70M
-8.70M
-0.272
-0.272
-0.272
-8.51M
-8.51M
3.20M
3.20M

Balance sheet

NBRV quarterly balance sheet
1.92M
1.92M
10.51M
23.69M
263.00K
24.34M
197.00K
542.00K
28.00M
345.00K
28.70M
-661.56M
27.00K
-4.36M
-4.36M
644.00K
542.00K
2.00K
9.03M
697.00K
6.98M

Cash flow

NBRV quarterly cash flow
21.00K
-4.85M
-10.62M
-3.00K
-4.85M
-3.00K
-5.62M
-143.00K
999.00K
Advertisement